Cases & Deals

Perlan establishes global patent portfolio for ICAM1 antibodies

Clients Perlan Therapeutics, Inc.

Jones Day represents Perlan Therapeutics, Inc. in connection with the global patent portfolio for ICAM1 antibodies for the treatment of rhinovirus and other respiratory infections.